Company Profile

Journey Medical Corporation Stock Price, News & Catalysts

Ticker:
DERM
Exchange:
NASDAQ
Sector:
Biopharma
Location:
United States

Stock performance

3.55 USD (-3.79%)

Close

Last updated: November 19, 2026

166M USD

Market cap

Why the stock is moving

As of Nov 19, 2026, DERM closed down 3.79% at $3.55. No new same-company headline was identified in the current news window.

Company overview

Prescription Dermatology Company

Journey Medical develops, acquires, and commercializes FDA-approved prescription products for dermatologic conditions through a specialist sales organization.

Emrosi

Emrosi is an oral treatment for inflammatory lesions of rosacea and is central to Journey Medical's current commercial expansion. The product broadens the company's presence in a large chronic dermatology market.

Established Portfolio

Journey Medical markets nine branded prescription drugs for common skin conditions. This portfolio allows the same commercial infrastructure to support multiple products and physician relationships.

Focused Commercial Model

The company emphasizes targeted product acquisition and specialist promotion rather than maintaining a broad internal discovery platform. Journey Medical was founded by Fortress Biotech but operates as a separately listed company.

Future catalysts

  • Planned commercial launch of Tome Clearing Treatment for acne in the first half of 2027, subject to successful development.

Recent news

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

Similar stocks

Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

Frequently Asked Questions

What is the current stock price of Journey Medical Corporation (DERM)?

Journey Medical Corporation (DERM) most recently closed at 3.55 USD, a -3.79% move versus the previous session.

What is the market cap of Journey Medical Corporation (DERM)?

Journey Medical Corporation currently has a market capitalization of 166M USD on BioPharmSignal.

What does Journey Medical Corporation do?

Prescription Dermatology Company Journey Medical develops, acquires, and commercializes FDA-approved prescription products for dermatologic conditions through a specialist sales organization. Emrosi Emrosi is an oral treatment for inflammatory lesions of rosacea and is central to Journey Medical's current commercial expansion. The product broadens the...

On which exchange is DERM stock listed?

Journey Medical Corporation (DERM) is associated with NASDAQ, United States, Biopharma.

What is Prescription?

Prescription Dermatology Company Journey Medical develops, acquires, and commercializes FDA-approved prescription products for dermatologic conditions through a specialist sales organization.

Which conditions is Journey Medical Corporation targeting with Prescription?

Journey Medical Corporation is associated with dermatology based on its company overview and current catalyst commentary.

How does Journey Medical Corporation describe recent progress with Prescription?

Planned commercial launch of Tome Clearing Treatment for acne in the first half of 2027, subject to successful development.

What is Dermatology?

Prescription Dermatology Company Journey Medical develops, acquires, and commercializes FDA-approved prescription products for dermatologic conditions through a specialist sales organization.